HLA-B*58:01 screening to prevent allopurinol-induced severe cutaneous adverse reactions in Chinese patients with chronic kidney disease-Reference-Cited by-同舟云学术

HLA-B*58:01 screening to prevent allopurinol-induced severe cutaneous adverse reactions in Chinese patients with chronic kidney disease

Published:2021-07-02 Issue: Volume: Page:
ISSN:0340-3696
Container-title:Archives of Dermatological Research
language:en
Short-container-title:Arch Dermatol Res

Author:

Wong Christina Sze-Man,Yeung Chi-Keung,Chan Chun-Yin,Yap Desmond Yat-Hin,Tang Sydney Chi-Wai,Cheung Bernard Man-Yung,Kwok Janette Siu-Yin,Chan Henry Hin-Lee^ORCID

Funder

S.K Yee Medical Foundation

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00403-021-02258-3.pdf

Reference42 articles.

1. Chung WH, Hung SI, Chen YT (2007) Human leukocyte antigens and drug hypersensitivity. Curr Opin Allergy Clin Immunol 7:317–323. https://doi.org/10.1097/ACI.0b013e3282370c5f

2. Hung SI, Chung WH, Liou LB et al (2005) HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 102:4134–4139. https://doi.org/10.1073/pnas.0409500102

3. Chiu ML, Hu M, Ng MH et al (2012) Association between HLA-B*58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong. Br J Dermatol 167:44–49. https://doi.org/10.1111/j.1365-2133.2012.10894.x

4. Goncalo M (2018) HLA-B*58:01 is not the only risk factor associated with allopurinol-induced severe cutaneous adverse drug reactions. Ann Transl Med 6:S7. https://doi.org/10.21037/atm.2018.08.42

5. Klein J, Sato A (2000) The HLA system. First of two parts. N Engl J Med 343:702–709. https://doi.org/10.1056/NEJM200009073431006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review;Frontiers in Immunology;2024-07-12

2. HLA-B*5801 testing: Is it time to consider mandatory testing prior to prescribing allopurinol in Singapore?;Annals of the Academy of Medicine, Singapore;2024-03-27

3. HLA-B*5801 testing: Is it time to consider mandatory testing prior to prescribing allopurinol in Singapore?;Annals of the Academy of Medicine, Singapore;2024-03-27

4. Drug-induced Stevens Johnson syndrome and toxic epidermal necrolysis: Interpreting the systematic reviews on immunomodulatory therapies;Asia Pacific Allergy;2023-06

5. Treatment of Gout in Hong Kong: Consensus and Controversy;Journal of Clinical Rheumatology and Immunology;2023-05-31